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Résumé en
anglais
Prosthetic joint infection (PJI) can occur with a wide range of microorganisms and
clinical features. After replacement surgery of prosthetic joint, prescription of
probabilistic broad-spectrum antimicrobial therapy is usual, while awaiting microbial
culture results. The aim of our study was to describe the antibiotic susceptibility of
microorganisms isolated from hip and knee PJI. The data were collected to determine
the best alternative to the usual combination of piperacillin-tazobactam (TZP) or
cefotaxime (CTX) and vancomycin (VAN). Based on a French prospective, multicenter
study, we analyzed microbiological susceptibility to antibiotics of 183 strains isolated
from patients with confirmed hip or knee PJI. In vitro susceptibility was evaluated:
TZP+VAN, TZP+linezolid (LZD), CTX+VAN, and CTX+LZD. We also analyzed
resistance to different antibiotics commonly used as oral alternatives. Among the 183
patients with PJI, 62 (34%) had a total knee prosthesis, and 121 (66%) a hip
prosthesis. The main identified bacteria were Staphylococcus aureus (32.2% of
isolates), coagulase-negative staphylococci (27.3%), Enterobacteriaceae (14.2%), and
Streptococcus (13.7%). Infections were polymicrobial for 28 (15.3%) patients. All
combinations were highly effective: CTX+VAN, CTX+LZD, TZP+VAN, and TZP+LZD
(93.4%, 94%, 98.4%, and 98.9% of all cases respectively). Use of LZD instead of VAN
in combination with a broad-spectrum beta-lactam covers almost all of the bacteria
isolated in PJI. This association should be considered in probabilistic chemotherapy,
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